Funding Details
- Awarder
- Inbox
- Date Award
- June 30, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Exsilio Therapeutics is a biotechnology company developing genomic medicines for a broad range of diseases. They are focused on delivering genomic medicines in lipid nanoparticles to treat genetic diseases, cancer, and autoimmune conditions. Their technology involves precise insertion of therapeutic genes into safe harbor sites of disease-relevant cells using naturally occurring genetic elements.
- Market
- Healthcare
- Location
-
Boston,
MA,
US
- Coinvestors
- Novartis Venture Fund, Delos Capital, OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures, Deep Insight
Links